-
Something wrong with this record ?
Multimodal therapy for chronic tinnitus
A Hahn, L Radkova, G Achiemere, V Klement, D Alpini, J Strouhal
Language English Country United States
Document type Comparative Study
PubMed
18616089
Knihovny.cz E-resources
- MeSH
- Betahistine therapeutic use MeSH
- Chronic Disease MeSH
- Cinnarizine therapeutic use MeSH
- Dimenhydrinate therapeutic use MeSH
- Adult MeSH
- Drug Combinations MeSH
- Drug Therapy, Combination MeSH
- Combined Modality Therapy MeSH
- Low-Level Light Therapy MeSH
- Middle Aged MeSH
- Humans MeSH
- Lidocaine therapeutic use MeSH
- Pentoxifylline therapeutic use MeSH
- Retrospective Studies MeSH
- Plant Extracts therapeutic use MeSH
- Aged MeSH
- Physical Therapy Modalities MeSH
- Tinnitus rehabilitation MeSH
- Vinca Alkaloids therapeutic use MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Comparative Study MeSH
From 2001 to 2006, we performed a retrospective study of patients suffering from chronic unilateral or bilateral tinnitus that was previously ineffectively treated by oral drugs [betahistine (Betaserc), extract of Ginkgo biloba (EGb 761), tanakan (Tebokan), and cinnarizine-dimenhydrinate (Arlevert), singly or in combination]. We divided 150 tinnitus patients (80 men, 70 women) into seven treatment groups. Treatments consisted of application of intravenous pentoxifylline, lidocaine, or vinpocetine (Cavinton) and combination of these agents with physiotherapy and soft laser. Mean duration (+/- standard deviation) of tinnitus in these patients was 7.4 +/- 6.0 years; their mean age was 55.6 +/- 12.5 years. The aim of our study was to compare treatment modalities and define their effectiveness for tinnitus relief. The most effective treatment was defined as a combination of Cavinton and physiotherapy. We evaluated pure lidocaine infusion therapy as ineffective. None of the treatment modalities had an objective correlate of improvement, though improvement was reported by a visual analog scale.
- 000
- 02922naa 2200517 a 4500
- 001
- bmc11003828
- 003
- CZ-PrNML
- 005
- 20130617120523.0
- 008
- 110302s2008 xxu e eng||
- 009
- AR
- 035 __
- $a (PubMed)18616089
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Hahn, Aleš, $d 1947-2020 $7 nlk19990073180
- 245 10
- $a Multimodal therapy for chronic tinnitus / $c A Hahn, L Radkova, G Achiemere, V Klement, D Alpini, J Strouhal
- 314 __
- $a Ear, Nose, and Throat Department, Third Medical Faculty, Charles University, Prague, Czech Republic. hahn@fnkv.cz
- 520 9_
- $a From 2001 to 2006, we performed a retrospective study of patients suffering from chronic unilateral or bilateral tinnitus that was previously ineffectively treated by oral drugs [betahistine (Betaserc), extract of Ginkgo biloba (EGb 761), tanakan (Tebokan), and cinnarizine-dimenhydrinate (Arlevert), singly or in combination]. We divided 150 tinnitus patients (80 men, 70 women) into seven treatment groups. Treatments consisted of application of intravenous pentoxifylline, lidocaine, or vinpocetine (Cavinton) and combination of these agents with physiotherapy and soft laser. Mean duration (+/- standard deviation) of tinnitus in these patients was 7.4 +/- 6.0 years; their mean age was 55.6 +/- 12.5 years. The aim of our study was to compare treatment modalities and define their effectiveness for tinnitus relief. The most effective treatment was defined as a combination of Cavinton and physiotherapy. We evaluated pure lidocaine infusion therapy as ineffective. None of the treatment modalities had an objective correlate of improvement, though improvement was reported by a visual analog scale.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a betahistin $x terapeutické užití $7 D001621
- 650 _2
- $a chronická nemoc $7 D002908
- 650 _2
- $a cinarizin $x terapeutické užití $7 D002936
- 650 _2
- $a kombinovaná terapie $7 D003131
- 650 _2
- $a dimenhydrinát $x terapeutické užití $7 D004111
- 650 _2
- $a fixní kombinace léků $7 D004338
- 650 _2
- $a kombinovaná farmakoterapie $7 D004359
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a laserová terapie s nízkou intenzitou světla $7 D028022
- 650 _2
- $a lidokain $x terapeutické užití $7 D008012
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a pentoxifylin $x terapeutické užití $7 D010431
- 650 _2
- $a techniky fyzikální terapie $7 D026741
- 650 _2
- $a rostlinné extrakty $x terapeutické užití $7 D010936
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a tinnitus $x rehabilitace $7 D014012
- 650 _2
- $a vinca alkaloidy $x terapeutické užití $7 D014748
- 655 _2
- $a srovnávací studie $7 D003160
- 700 1_
- $a Radková, Lenka $7 xx0134724
- 700 1_
- $a Achiemere, Gabriela $7 xx0084386
- 700 1_
- $a Klement, Vladislav $7 xx0098380
- 700 1_
- $a Alpini, Dario, $d 1958- $7 xx0123645
- 700 1_
- $a Strouhal, Jaroslav. $7 _AN059577
- 773 0_
- $t International Tinnitus Journal $w MED00155658 $g Roč. 14, č. 1 (2008), s. 69-72 $x 0946-5448
- 910 __
- $a ABA008 $b x $y 6
- 990 __
- $a 20110404091336 $b ABA008
- 991 __
- $a 20130617120911 $b ABA008
- 999 __
- $a ok $b bmc $g 831174 $s 695852
- BAS __
- $a 3
- BMC __
- $a 2008 $b 14 $c 1 $d 69-72 $i 0946-5448 $m The international tinnitus journal $n Int Tinnitus J $x MED00155658
- LZP __
- $a 2011-3B/irme